Managing the risks posed by hazardous chemicals in a pharmaceutical company

Case study
Lotyšsko
English
2018

Popis

The Latvian pharmaceutical company on which this case study focuses found that involving workers in the identification of occupational safety and health problems — and indeed in all stages of an intervention to improve safety and health — is crucial for implementing effective prevention measures. The company implemented measures to significantly reduce or eliminate exposures to carcinogens, mutagens, reprotoxic substances and other hazardous chemicals among its workers, in particular pregnant and breastfeeding workers.

Other data

Sector / Industry covered: 
ZPRACOVATELSKÝ PRŮMYSL
Výroba základních farmaceutických výrobků
Provider: 
JSC Grindeks, Riga, Latvia
Tasks covered: 
Handling Chemicals
Processing Materials
Hazard - physical state: 
Aerosols
Dusts
Liquids
Hazard - health effects: 
Allergens
Skin sensitisers
Asphyxiants
Carcinogens
Neurotoxic substances
Exposure route: 
Dermal contact
Inhalation
Substance Description: 

Fluorouracil (active pharmaceutical ingredient)

CAS Number: 
51-21-8
EC number: 
200-085-6
Prevention measures: 
Level 1. Elimination of hazards
Level 2. Technical measures, e.g. local exhaust ventilation
Level 2. Reducing / minimising the risk by organisational measures, e.g. reducing the number of workers exposed
Level 3. Reducing / minimising the risk by personal measures (PPE)
Training / guidance
Hygiene measures
Purpose of the material: 
Awareness raising
Guidance
Other
Target group: 
Employers
Managers
OSH consultant
Safety officers
Supervisor
Trainers
Workers representatives

Access tool